Effect of intermittent use of low-dose urokinase on pulmonary embolism
10.3969/j.issn.1006-5725.2015.07.029
- VernacularTitle:间断小剂量尿激酶治疗肺栓塞临床观察
- Author:
Lei LEI
;
Junlan YANG
;
Haoqun XIE
;
Jia CUI
- Publication Type:Journal Article
- Keywords:
Pulmonary embolism;
Low-dose urokinase;
rt-PA;
Thrombolysis
- From:
The Journal of Practical Medicine
2015;(7):1134-1136
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of intermittent use of low-dose urokinase in the treatment of pulmonary embolism. Methods Forty-two patients with acute pulmonary embolism were divided into UK group with UK 10 000 U/(kg·d),7 days and rt-PA group with rt-PA 50 mg/2 h randomly. The efficacy was determined by the improvement of right heart dysfunction and perfusion defect 8 d and 14 d after the treatment. The bleeding incidence, death rate and PE recurrence were also evaluated. Results Differences of right heart dysfunction and perfusion defect between UK group and rt-PA group indicated no statistical significance (P >0.05).The rate of bleeding in UK group was lower than that of rt-PA group. Conclution The intermittent use of low-dose urokinase in the treatment of pulmonary embolism exhibits similar efficacy as rt-PA.
